> top > docs > PMC:1472690 > spans > 31160-32193 > annotations

PMC:1472690 / 31160-32193 JSONTXT

Annnotations TAB JSON ListView MergeView

pmc-enju-pas

Id Subject Object Predicate Lexical cue
T14240 1029-1031 CD denotes 51
T14239 1028-1029 -LRB- denotes [
T14238 1022-1027 NN denotes parts
T14237 1018-1021 DT denotes all
T14236 1015-1017 IN denotes in
T14235 1004-1014 JJ denotes equivalent
T14234 1000-1003 RB denotes not
T14233 996-999 VB denotes are
T14232 990-995 WDT denotes which
T14231 982-989 NN denotes signals
T14230 979-981 IN denotes of
T14229 968-978 JJ denotes suggestive
T14228 966-967 -COMMA- denotes ,
T14227 955-966 NN denotes combination
T14226 952-954 IN denotes in
T14225 936-951 RB denotes synergistically
T14224 930-935 VB denotes acted
T14223 926-929 CC denotes and
T14222 917-925 NN denotes proteins
T14221 894-916 JJ denotes mechanisms/DNA-binding
T14220 884-893 JJ denotes different
T14219 876-883 IN denotes through
T14218 871-875 NN denotes gene
T14217 864-870 NN denotes IL-1RA
T14216 860-863 DT denotes the
T14215 850-859 VB denotes activated
T14214 836-849 NN denotes peptidoglycan
T14213 832-835 CC denotes and
T14212 828-831 NN denotes LPS
T14211 826-827 -COMMA- denotes ,
T14210 823-826 NN denotes PRR
T14209 815-822 JJ denotes similar
T14208 812-814 IN denotes of
T14207 808-811 NN denotes use
T14206 804-807 DT denotes the
T14205 796-803 IN denotes despite
T14204 791-795 IN denotes that
T14203 783-790 VB denotes showing
T14202 777-782 NN denotes study
T14201 769-776 DT denotes another
T14200 766-768 IN denotes by
T14199 756-765 VB denotes supported
T14198 753-755 VB denotes be
T14197 749-752 MD denotes may
T14196 744-748 NN denotes idea
T14195 739-743 DT denotes This
T14194 736-737 -RRB- denotes )
T14193 727-736 NN denotes signaling
T14192 720-726 NN denotes kinase
T14191 702-719 JJ denotes mitogen-activated
T14190 701-702 -LRB- denotes (
T14189 697-700 NN denotes LPS
T14188 693-696 CC denotes and
T14187 691-692 -RRB- denotes )
T14186 687-691 NN denotes PI3K
T14185 686-687 -LRB- denotes (
T14184 683-685 NN denotes GP
T14183 675-682 IN denotes between
T14182 665-674 NN denotes signaling
T14181 662-664 IN denotes in
T14180 651-661 NN denotes difference
T14179 649-650 DT denotes a
T14178 645-648 IN denotes for
T14177 633-644 NN denotes explanation
T14176 630-632 DT denotes an
T14175 624-629 VB denotes offer
T14174 620-623 MD denotes may
T14158 555-557 CD denotes 49
T14157 554-555 -LRB- denotes [
T14156 548-553 NN denotes cells
T14155 546-547 NN denotes T
T14154 543-545 IN denotes in
T14153 538-542 NN denotes NFAT
T14152 535-537 IN denotes of
T14151 524-534 NN denotes activation
T14150 520-523 DT denotes the
T14149 517-519 IN denotes in
T14148 508-516 VB denotes involved
T14147 505-507 VB denotes be
T14146 502-504 TO denotes to
T14145 493-501 VB denotes reported
T14144 488-492 VB denotes been
T14143 484-487 VB denotes has
T14142 479-483 NN denotes PI3K
T14141 475-478 IN denotes via
T14140 465-474 NN denotes Signaling
T14139 462-463 -RRB- denotes ]
T14138 460-462 CD denotes 48
T14137 459-460 -LRB- denotes [
T14136 448-458 NN denotes production
T14135 442-447 NN denotes IL-1β
T14134 438-441 RB denotes not
T14133 434-437 CC denotes but
T14132 426-433 NN denotes sIL-1RA
T14131 417-425 VB denotes controls
T14130 405-416 RB denotes selectively
T14129 397-404 NN denotes pathway
T14128 392-396 NN denotes PI3K
T14127 388-391 DT denotes the
T14126 377-387 NN denotes leukocytes
T14125 358-376 JJ denotes septic/LPS-adapted
T14124 355-357 IN denotes in
T14123 350-354 IN denotes that
T14122 337-349 VB denotes demonstrated
T14121 332-336 VB denotes been
T14120 328-331 VB denotes has
T14119 325-327 PRP denotes It
T14118 322-323 -RRB- denotes ]
T14117 317-322 CD denotes 22,37
T14116 316-317 -LRB- denotes [
T14115 306-315 NN denotes treatment
T14114 303-305 NN denotes GP
T14113 300-302 IN denotes by
T14112 290-299 VB denotes sustained
T14111 287-289 VB denotes be
T14110 283-286 MD denotes may
T14109 276-282 NN denotes effect
T14108 271-275 DT denotes this
T14107 267-270 CC denotes and
T14106 265-266 -RRB- denotes ]
T14105 263-265 CD denotes 44
T14104 262-263 -LRB- denotes [
T14103 252-261 NN denotes signaling
T14102 248-251 IN denotes for
T14101 240-247 NN denotes pathway
T14100 235-239 NN denotes PI3K
T14099 231-234 DT denotes the
T14098 227-230 VB denotes use
T14097 224-226 TO denotes to
T14096 218-223 VB denotes shown
T14095 213-217 VB denotes been
T14094 209-212 VB denotes has
T14093 202-208 NN denotes TSST-1
T14092 199-200 -RRB- denotes ]
T14091 194-199 CD denotes 43-45
T14090 193-194 -LRB- denotes [
T14089 186-192 NN denotes TSST-1
T14088 182-185 CC denotes and
T14087 178-181 NN denotes LPS
T14086 170-177 IN denotes between
T14085 161-169 NN denotes pathways
T14084 151-160 NN denotes signaling
T14083 148-150 IN denotes in
T14082 136-147 NN denotes differences
T14081 127-135 JJ denotes balanced
T14080 116-126 RB denotes delicately
T14079 113-115 TO denotes to
T14078 102-112 VB denotes attributed
T14077 99-101 VB denotes be
T14076 95-98 MD denotes may
T14075 93-94 -COMMA- denotes ,
T14074 88-93 NN denotes study
T14073 83-87 DT denotes this
T14072 80-82 IN denotes in
T14071 71-79 VB denotes observed
T14070 62-70 NN denotes response
T14069 55-61 JJ denotes immune
T14068 43-54 JJ denotes LPS-induced
T14067 39-42 DT denotes the
T14066 36-38 IN denotes on
T14065 33-35 NN denotes GP
T14064 30-32 IN denotes of
T14063 22-29 NN denotes effects
T14062 11-21 JJ denotes modulating
T14061 4-10 JJ denotes weaker
T14060 0-3 DT denotes The
T14241 1031-1032 -RRB- denotes ]
T14173 614-619 WDT denotes which
T14172 612-613 -COMMA- denotes ,
T14171 611-612 -RRB- denotes ]
T14170 609-611 CD denotes 50
T14169 608-609 -LRB- denotes [
T14168 603-607 NN denotes PI3K
T14167 599-602 IN denotes via
T14166 593-598 NN denotes place
T14165 588-592 VB denotes take
T14164 583-587 RB denotes also
T14163 579-582 MD denotes can
T14162 574-578 NN denotes NFκB
T14161 571-573 IN denotes of
T14160 560-570 NN denotes Activation
T14159 557-558 -RRB- denotes ]
R9178 T14063 T14060 arg1Of effects,The
R9194 T14063 T14061 arg1Of effects,weaker
R9195 T14063 T14062 arg1Of effects,modulating
R9196 T14063 T14064 arg1Of effects,of
R9197 T14063 T14066 arg1Of effects,on
R9203 T14063 T14076 arg1Of effects,may
R9204 T14063 T14077 arg1Of effects,be
R9206 T14063 T14078 arg2Of effects,attributed
R9215 T14065 T14064 arg2Of GP,of
R9220 T14070 T14066 arg2Of response,on
R9233 T14070 T14067 arg1Of response,the
R9236 T14070 T14068 arg1Of response,LPS-induced
R9237 T14070 T14069 arg1Of response,immune
R9238 T14070 T14071 arg2Of response,observed
R9240 T14071 T14072 arg1Of observed,in
R9243 T14074 T14072 arg2Of study,in
R9253 T14074 T14073 arg1Of study,this
R9254 T14078 T14075 arg1Of attributed,","
R9262 T14078 T14076 arg2Of attributed,may
R9265 T14078 T14077 arg2Of attributed,be
R9266 T14078 T14079 arg1Of attributed,to
R9267 T14081 T14080 arg1Of balanced,delicately
R9268 T14082 T14079 arg2Of differences,to
R9269 T14082 T14081 arg1Of differences,balanced
R9270 T14082 T14083 arg1Of differences,in
R9271 T14085 T14083 arg2Of pathways,in
R9272 T14159 T14157 arg3Of ],[
R9273 T14085 T14084 arg1Of pathways,signaling
R9274 T14085 T14086 arg1Of pathways,between
R9275 T14160 T14161 arg1Of Activation,of
R9276 T14160 T14163 arg1Of Activation,can
R9277 T14160 T14165 arg1Of Activation,take
R9278 T14087 T14088 arg1Of LPS,and
R9279 T14162 T14161 arg2Of NFκB,of
R9280 T14165 T14163 arg2Of take,can
R9281 T14165 T14164 arg1Of take,also
R9282 T14165 T14167 arg1Of take,via
R9283 T14088 T14086 arg2Of and,between
R9284 T14166 T14165 arg2Of place,take
R9285 T14168 T14167 arg2Of PI3K,via
R9286 T14168 T14169 arg1Of PI3K,[
R9287 T14168 T14172 arg1Of PI3K,","
R9288 T14168 T14173 arg1Of PI3K,which
R9289 T14168 T14174 arg1Of PI3K,may
R9290 T14168 T14175 arg1Of PI3K,offer
R9291 T14170 T14169 arg2Of 50,[
R9292 T14171 T14169 arg3Of ],[
R9293 T14088 T14090 arg1Of and,[
R9294 T14175 T14174 arg2Of offer,may
R9295 T14089 T14088 arg2Of TSST-1,and
R9296 T14177 T14175 arg2Of explanation,offer
R9297 T14177 T14176 arg1Of explanation,an
R9298 T14177 T14178 arg1Of explanation,for
R9299 T14091 T14090 arg2Of 43-45,[
R9300 T14180 T14178 arg2Of difference,for
R9301 T14180 T14179 arg1Of difference,a
R9302 T14180 T14181 arg1Of difference,in
R9303 T14180 T14183 arg1Of difference,between
R9304 T14182 T14181 arg2Of signaling,in
R9305 T14092 T14090 arg3Of ],[
R9306 T14093 T14094 arg1Of TSST-1,has
R9307 T14093 T14095 arg1Of TSST-1,been
R9308 T14093 T14096 arg2Of TSST-1,shown
R9311 T14093 T14098 arg1Of TSST-1,use
R9313 T14096 T14094 arg2Of shown,has
R9318 T14096 T14095 arg2Of shown,been
R9319 T14096 T14107 arg1Of shown,and
R9321 T14098 T14096 arg3Of use,shown
R9328 T14196 T14199 arg2Of idea,supported
R9329 T14098 T14097 arg1Of use,to
R9330 T14098 T14104 arg1Of use,[
R9331 T14199 T14197 arg2Of supported,may
R9332 T14199 T14198 arg2Of supported,be
R9333 T14101 T14098 arg2Of pathway,use
R9334 T14202 T14199 arg1Of study,supported
R9335 T14202 T14200 arg2Of study,by
R9336 T14202 T14201 arg1Of study,another
R9337 T14202 T14203 arg1Of study,showing
R9338 T14101 T14099 arg1Of pathway,the
R9339 T14207 T14205 arg2Of use,despite
R9340 T14207 T14206 arg1Of use,the
R9341 T14207 T14208 arg1Of use,of
R9342 T14210 T14208 arg2Of PRR,of
R9343 T14210 T14209 arg1Of PRR,similar
R9344 T14101 T14100 arg1Of pathway,PI3K
R9345 T14212 T14213 arg1Of LPS,and
R9346 T14101 T14102 arg1Of pathway,for
R9347 T14213 T14215 arg1Of and,activated
R9348 T14213 T14224 arg1Of and,acted
R9349 T14213 T14229 arg1Of and,suggestive
R9350 T14214 T14213 arg2Of peptidoglycan,and
R9351 T14103 T14102 arg2Of signaling,for
R9352 T14215 T14219 arg1Of activated,through
R9353 T14215 T14223 arg1Of activated,and
R9354 T14218 T14215 arg2Of gene,activated
R9355 T14218 T14216 arg1Of gene,the
R9356 T14218 T14217 arg1Of gene,IL-1RA
R9357 T14105 T14104 arg2Of 44,[
R9358 T14222 T14219 arg2Of proteins,through
R9359 T14222 T14220 arg1Of proteins,different
R9360 T14222 T14221 arg1Of proteins,mechanisms/DNA-binding
R9361 T14223 T14203 arg2Of and,showing
R9362 T14223 T14204 arg1Of and,that
R9363 T14223 T14205 arg1Of and,despite
R9364 T14223 T14211 arg1Of and,","
R9365 T14223 T14228 arg1Of and,","
R9366 T14223 T14229 modOf and,suggestive
R9367 T14224 T14223 arg2Of acted,and
R9368 T14224 T14225 arg1Of acted,synergistically
R9369 T14224 T14226 arg1Of acted,in
R9370 T14106 T14104 arg3Of ],[
R9371 T14227 T14226 arg2Of combination,in
R9372 T14109 T14108 arg1Of effect,this
R9373 T14229 T14230 arg1Of suggestive,of
R9374 T14231 T14230 arg2Of signals,of
R9375 T14231 T14232 arg1Of signals,which
R9376 T14231 T14233 arg1Of signals,are
R9377 T14231 T14235 arg1Of signals,equivalent
R9378 T14233 T14234 arg1Of are,not
R9379 T14233 T14239 arg1Of are,[
R9380 T14109 T14110 arg1Of effect,may
R9381 T14235 T14233 arg2Of equivalent,are
R9382 T14235 T14236 arg1Of equivalent,in
R9383 T14109 T14111 arg1Of effect,be
R9384 T14109 T14112 arg2Of effect,sustained
R9385 T14238 T14236 arg2Of parts,in
R9386 T14238 T14237 arg1Of parts,all
R9387 T14112 T14107 arg2Of sustained,and
R9388 T14240 T14239 arg2Of 51,[
R9389 T14241 T14239 arg3Of ],[
R9390 T14112 T14110 arg2Of sustained,may
R9391 T14112 T14111 arg2Of sustained,be
R9392 T14112 T14116 arg1Of sustained,[
R9393 T14115 T14112 arg1Of treatment,sustained
R9394 T14115 T14113 arg2Of treatment,by
R9395 T14115 T14114 arg1Of treatment,GP
R9396 T14117 T14116 arg2Of "22,37",[
R9397 T14118 T14116 arg3Of ],[
R9398 T14119 T14120 arg1Of It,has
R9399 T14119 T14121 arg1Of It,been
R9400 T14119 T14122 arg2Of It,demonstrated
R9401 T14122 T14120 arg2Of demonstrated,has
R9402 T14122 T14121 arg2Of demonstrated,been
R9403 T14126 T14124 arg2Of leukocytes,in
R9404 T14126 T14125 arg1Of leukocytes,septic/LPS-adapted
R9405 T14129 T14127 arg1Of pathway,the
R9406 T14129 T14128 arg1Of pathway,PI3K
R9407 T14129 T14131 arg1Of pathway,controls
R9408 T14131 T14122 arg3Of controls,demonstrated
R9409 T14131 T14123 arg1Of controls,that
R9410 T14131 T14124 arg1Of controls,in
R9411 T14131 T14130 arg1Of controls,selectively
R9412 T14131 T14137 arg1Of controls,[
R9413 T14132 T14133 arg1Of sIL-1RA,but
R9414 T14133 T14131 arg2Of but,controls
R9415 T14133 T14134 arg1Of but,not
R9416 T14136 T14133 arg2Of production,but
R9417 T14136 T14135 arg1Of production,IL-1β
R9418 T14138 T14137 arg2Of 48,[
R9419 T14139 T14137 arg3Of ],[
R9420 T14140 T14141 arg1Of Signaling,via
R9421 T14140 T14143 arg1Of Signaling,has
R9422 T14140 T14144 arg1Of Signaling,been
R9423 T14140 T14145 arg2Of Signaling,reported
R9424 T14140 T14147 arg1Of Signaling,be
R9425 T14140 T14148 arg2Of Signaling,involved
R9426 T14142 T14141 arg2Of PI3K,via
R9427 T14145 T14143 arg2Of reported,has
R9428 T14145 T14144 arg2Of reported,been
R9429 T14148 T14145 arg3Of involved,reported
R9430 T14148 T14146 arg1Of involved,to
R9431 T14148 T14147 arg2Of involved,be
R9432 T14148 T14149 arg1Of involved,in
R9433 T14148 T14157 arg1Of involved,[
R9434 T14151 T14149 arg2Of activation,in
R9435 T14151 T14150 arg1Of activation,the
R9436 T14151 T14152 arg1Of activation,of
R9437 T14151 T14154 arg1Of activation,in
R9438 T14153 T14152 arg2Of NFAT,of
R9439 T14156 T14154 arg2Of cells,in
R9440 T14156 T14155 arg1Of cells,T
R9441 T14158 T14157 arg2Of 49,[
R9309 T14184 T14185 arg1Of GP,(
R9310 T14184 T14188 arg1Of GP,and
R9312 T14186 T14185 arg2Of PI3K,(
R9314 T14187 T14185 arg3Of ),(
R9315 T14188 T14183 arg2Of and,between
R9316 T14189 T14188 arg2Of LPS,and
R9317 T14189 T14190 arg1Of LPS,(
R9320 T14193 T14190 arg2Of signaling,(
R9322 T14193 T14191 arg1Of signaling,mitogen-activated
R9323 T14193 T14192 arg1Of signaling,kinase
R9324 T14194 T14190 arg3Of ),(
R9325 T14196 T14195 arg1Of idea,This
R9326 T14196 T14197 arg1Of idea,may
R9327 T14196 T14198 arg1Of idea,be

bionlp-st-ge-2016-test-proteins

Id Subject Object Predicate Lexical cue
T12411 864-870 Protein denotes IL-1RA
T12410 538-542 Protein denotes NFAT
T12409 442-447 Protein denotes IL-1β
T12408 427-433 Protein denotes IL-1RA
T12407 202-208 Protein denotes TSST-1
T12406 186-192 Protein denotes TSST-1

bionlp-st-ge-2016-uniprot

Id Subject Object Predicate Lexical cue
T14305 442-447 http://www.uniprot.org/uniprot/P01584 denotes IL-1β
T14276 864-870 http://www.uniprot.org/uniprot/P18510 denotes IL-1RA
T14325 202-208 http://www.uniprot.org/uniprot/P06886 denotes TSST-1
T14324 186-192 http://www.uniprot.org/uniprot/P06886 denotes TSST-1

GO-BP

Id Subject Object Predicate Lexical cue
T11938 240-261 http://purl.obolibrary.org/obo/GO_0007165 denotes pathway for signaling
T11937 151-169 http://purl.obolibrary.org/obo/GO_0007165 denotes signaling pathways
T11936 55-70 http://purl.obolibrary.org/obo/GO_0006955 denotes immune response
T11927 710-726 http://purl.obolibrary.org/obo/GO_0033674 denotes activated kinase
T11925 702-726 http://purl.obolibrary.org/obo/GO_0004707 denotes mitogen-activated kinase
T11909 982-989 http://purl.obolibrary.org/obo/GO_0023052 denotes signals
T11908 727-736 http://purl.obolibrary.org/obo/GO_0023052 denotes signaling
T11907 665-674 http://purl.obolibrary.org/obo/GO_0023052 denotes signaling
T11906 252-261 http://purl.obolibrary.org/obo/GO_0023052 denotes signaling
T11905 151-160 http://purl.obolibrary.org/obo/GO_0023052 denotes signaling
T11898 687-691 http://purl.obolibrary.org/obo/GO_0016303 denotes PI3K
T11897 603-607 http://purl.obolibrary.org/obo/GO_0016303 denotes PI3K
T11896 479-483 http://purl.obolibrary.org/obo/GO_0016303 denotes PI3K
T11895 392-396 http://purl.obolibrary.org/obo/GO_0016303 denotes PI3K
T11894 235-239 http://purl.obolibrary.org/obo/GO_0016303 denotes PI3K

GO-MF

Id Subject Object Predicate Lexical cue
T12572 909-925 http://purl.obolibrary.org/obo/GO_0005515 denotes binding proteins
T12563 905-916 http://purl.obolibrary.org/obo/GO_0003677 denotes DNA-binding
T12548 909-916 http://purl.obolibrary.org/obo/GO_0005488 denotes binding
T12525 687-691 http://purl.obolibrary.org/obo/GO_0016303 denotes PI3K
T12524 603-607 http://purl.obolibrary.org/obo/GO_0016303 denotes PI3K
T12523 479-483 http://purl.obolibrary.org/obo/GO_0016303 denotes PI3K
T12522 392-396 http://purl.obolibrary.org/obo/GO_0016303 denotes PI3K
T12521 235-239 http://purl.obolibrary.org/obo/GO_0016303 denotes PI3K

GO-CC

Id Subject Object Predicate Lexical cue
T12576 836-849 http://purl.obolibrary.org/obo/GO_0009274 denotes peptidoglycan
T12575 548-553 http://purl.obolibrary.org/obo/GO_0005623 denotes cells

sentences

Id Subject Object Predicate Lexical cue
T11891 739-1033 Sentence denotes This idea may be supported by another study showing that despite the use of similar PRR, LPS and peptidoglycan activated the IL-1RA gene through different mechanisms/DNA-binding proteins and acted synergistically in combination, suggestive of signals which are not equivalent in all parts [51].
T11890 560-738 Sentence denotes Activation of NFκB can also take place via PI3K [50], which may offer an explanation for a difference in signaling between GP (PI3K) and LPS (mitogen-activated kinase signaling).
T11889 465-559 Sentence denotes Signaling via PI3K has been reported to be involved in the activation of NFAT in T cells [49].
T11888 325-464 Sentence denotes It has been demonstrated that in septic/LPS-adapted leukocytes the PI3K pathway selectively controls sIL-1RA but not IL-1β production [48].
T11887 202-324 Sentence denotes TSST-1 has been shown to use the PI3K pathway for signaling [44] and this effect may be sustained by GP treatment [22,37].
T11886 0-201 Sentence denotes The weaker modulating effects of GP on the LPS-induced immune response observed in this study, may be attributed to delicately balanced differences in signaling pathways between LPS and TSST-1 [43-45].
T216 0-201 Sentence denotes The weaker modulating effects of GP on the LPS-induced immune response observed in this study, may be attributed to delicately balanced differences in signaling pathways between LPS and TSST-1 [43-45].
T217 202-324 Sentence denotes TSST-1 has been shown to use the PI3K pathway for signaling [44] and this effect may be sustained by GP treatment [22,37].
T218 325-464 Sentence denotes It has been demonstrated that in septic/LPS-adapted leukocytes the PI3K pathway selectively controls sIL-1RA but not IL-1β production [48].
T219 465-559 Sentence denotes Signaling via PI3K has been reported to be involved in the activation of NFAT in T cells [49].
T220 560-738 Sentence denotes Activation of NFκB can also take place via PI3K [50], which may offer an explanation for a difference in signaling between GP (PI3K) and LPS (mitogen-activated kinase signaling).
T221 739-1033 Sentence denotes This idea may be supported by another study showing that despite the use of similar PRR, LPS and peptidoglycan activated the IL-1RA gene through different mechanisms/DNA-binding proteins and acted synergistically in combination, suggestive of signals which are not equivalent in all parts [51].

simple1

Id Subject Object Predicate Lexical cue
T12790 864-870 Protein denotes IL-1RA
T12789 538-542 Protein denotes NFAT
T12788 442-447 Protein denotes IL-1β
T12787 427-433 Protein denotes IL-1RA
T12786 202-208 Protein denotes TSST-1
T12785 186-192 Protein denotes TSST-1

BioNLP16_DUT

Id Subject Object Predicate Lexical cue
T16685 850-859 Positive_regulation denotes activated
T16684 524-534 Positive_regulation denotes activation
T16683 448-458 Gene_expression denotes production
T16682 417-425 Regulation denotes controls
T16628 864-870 Protein denotes IL-1RA
T16627 538-542 Protein denotes NFAT
T16626 442-447 Protein denotes IL-1β
T16625 427-433 Protein denotes IL-1RA
T16624 202-208 Protein denotes TSST-1
T16623 186-192 Protein denotes TSST-1
R11405 T16683 T16682 themeOf production,controls
R11424 T16626 T16683 themeOf IL-1β,production
R11425 T16627 T16684 themeOf NFAT,activation
R11428 T16628 T16685 themeOf IL-1RA,activated

BioNLP16_Messiy

Id Subject Object Predicate Lexical cue
T14504 850-859 Positive_regulation denotes activated
T14503 524-534 Positive_regulation denotes activation
T14502 448-458 Gene_expression denotes production
T14436 864-870 Protein denotes IL-1RA
T14435 538-542 Protein denotes NFAT
T14434 442-447 Protein denotes IL-1β
T14433 427-433 Protein denotes IL-1RA
T14432 202-208 Protein denotes TSST-1
T14431 186-192 Protein denotes TSST-1
R9656 T14434 T14502 themeOf IL-1β,production
R9661 T14435 T14503 themeOf NFAT,activation
R9662 T14436 T14504 themeOf IL-1RA,activated

DLUT931

Id Subject Object Predicate Lexical cue
T14686 850-859 Positive_regulation denotes activated
T14685 508-516 Regulation denotes involved
T14684 524-534 Positive_regulation denotes activation
T14683 417-425 Regulation denotes controls
T14682 448-458 Gene_expression denotes production
T14611 864-870 Protein denotes IL-1RA
T14610 538-542 Protein denotes NFAT
T14609 442-447 Protein denotes IL-1β
T14608 427-433 Protein denotes IL-1RA
T14607 202-208 Protein denotes TSST-1
T14606 186-192 Protein denotes TSST-1
R9718 T14682 T14683 themeOf production,controls
R9719 T14684 T14685 themeOf activation,involved
R9657 T14609 T14682 themeOf IL-1β,production
R9658 T14610 T14684 themeOf NFAT,activation
R9659 T14611 T14686 themeOf IL-1RA,activated

bionlp-st-ge-2016-test-ihmc

Id Subject Object Predicate Lexical cue
T16926 178-181 Entity denotes LPS
T16922 683-692 Protein denotes GP (PI3K)
T16915 687-691 Protein denotes PI3K
T16913 43-54 Entity denotes LPS-induced
T16905 697-700 Entity denotes LPS
T16901 231-247 Protein denotes the PI3K pathway
T16895 812-826 Protein denotes of similar PRR
T16892 905-925 Protein denotes DNA-binding proteins
T16890 479-483 Protein denotes PI3K
T16888 702-719 Entity denotes mitogen-activated
T16856 426-431 Protein denotes sIL-1
T16855 603-613 Protein denotes PI3K [50],
T16854 186-192 Protein denotes TSST-1
T16835 202-208 Protein denotes TSST-1
T16817 303-305 Protein denotes GP
T16799 720-726 Protein denotes kinase
T16796 388-404 Protein denotes the PI3K pathway
T16789 546-558 Entity denotes T cells [49]
T16779 442-447 Protein denotes IL-1β
T16773 560-578 Protein denotes Activation of NFκB
T16764 828-831 Entity denotes LPS
T16761 377-387 Entity denotes leukocytes
T16755 33-35 Protein denotes GP
T16746 426-433 Protein denotes sIL-1RA
T16718 864-870 Protein denotes IL-1RA
T16703 836-849 Entity denotes peptidoglycan
T16700 860-875 Protein denotes the IL-1RA gene
T16694 535-542 Protein denotes of NFAT
T16964 517-558 Positive_regulation denotes in the activation of NFAT in T cells [49]
T16963 388-463 Regulation denotes the PI3K pathway selectively controls sIL-1RA but not IL-1β production [48]
T16961 303-323 Regulation denotes GP treatment [22,37]
T16960 828-925 Positive_regulation denotes LPS and peptidoglycan activated the IL-1RA gene through different mechanisms/DNA-binding proteins
T16959 828-925 Positive_regulation denotes LPS and peptidoglycan activated the IL-1RA gene through different mechanisms/DNA-binding proteins
T16944 442-463 Gene_expression denotes IL-1β production [48]
T16942 702-736 Positive_regulation denotes mitogen-activated kinase signaling
R11411 T16694 T16964 themeOf of NFAT,in the activation of NFAT in T cells [49]
R11415 T16700 T16959 themeOf the IL-1RA gene,LPS and peptidoglycan activated the IL-1RA gene through different mechanisms/DNA-binding proteins
R11416 T16700 T16960 themeOf the IL-1RA gene,LPS and peptidoglycan activated the IL-1RA gene through different mechanisms/DNA-binding proteins
R11417 T16703 T16959 causeOf peptidoglycan,LPS and peptidoglycan activated the IL-1RA gene through different mechanisms/DNA-binding proteins
R11439 T16746 T16963 themeOf sIL-1RA,the PI3K pathway selectively controls sIL-1RA but not IL-1β production [48]
R11452 T16764 T16960 causeOf LPS,LPS and peptidoglycan activated the IL-1RA gene through different mechanisms/DNA-binding proteins
R11460 T16779 T16944 themeOf IL-1β,IL-1β production [48]
R11469 T16799 T16942 causeOf kinase,mitogen-activated kinase signaling
R11480 T16817 T16961 themeOf GP,"GP treatment [22,37]"

bionlp-st-ge-2016-spacy-parsed

Id Subject Object Predicate Lexical cue
T16328 1032-1033 . denotes .
T16327 1031-1032 NNP denotes ]
T16326 1029-1031 CD denotes 51
T16325 1028-1029 NNP denotes [
T16324 1022-1027 NNS denotes parts
T16323 1018-1021 DT denotes all
T16322 1015-1017 IN denotes in
T16321 1004-1014 JJ denotes equivalent
T16320 1000-1003 RB denotes not
T16319 996-999 VBP denotes are
T16318 990-995 WDT denotes which
T16317 982-989 NNS denotes signals
T16316 979-981 IN denotes of
T16315 968-978 NN denotes suggestive
T16314 966-967 , denotes ,
T16313 955-966 NN denotes combination
T16312 952-954 IN denotes in
T16311 936-951 RB denotes synergistically
T16310 930-935 VBD denotes acted
T16309 926-929 CC denotes and
T16308 917-925 NNS denotes proteins
T16307 894-916 JJ denotes mechanisms/DNA-binding
T16306 884-893 JJ denotes different
T16305 876-883 IN denotes through
T16304 871-875 NN denotes gene
T16303 864-870 NNP denotes IL-1RA
T16302 860-863 DT denotes the
T16301 850-859 VBN denotes activated
T16300 836-849 JJ denotes peptidoglycan
T16299 832-835 CC denotes and
T16298 828-831 NNP denotes LPS
T16297 826-827 , denotes ,
T16296 823-826 NNP denotes PRR
T16295 815-822 JJ denotes similar
T16294 812-814 IN denotes of
T16293 808-811 NN denotes use
T16292 804-807 DT denotes the
T16291 796-803 IN denotes despite
T16290 791-795 IN denotes that
T16289 783-790 VBG denotes showing
T16288 777-782 NN denotes study
T16287 769-776 DT denotes another
T16286 766-768 IN denotes by
T16285 756-765 VBN denotes supported
T16284 753-755 VB denotes be
T16283 749-752 MD denotes may
T16282 744-748 NN denotes idea
T16281 739-743 DT denotes This
T16280 737-738 . denotes .
T16279 736-737 -RRB- denotes )
T16278 727-736 VBG denotes signaling
T16277 720-726 NN denotes kinase
T16276 702-719 JJ denotes mitogen-activated
T16275 701-702 -LRB- denotes (
T16274 697-700 NNP denotes LPS
T16273 693-696 CC denotes and
T16272 691-692 -RRB- denotes )
T16271 687-691 NNP denotes PI3K
T16270 686-687 -LRB- denotes (
T16269 683-685 NNP denotes GP
T16268 675-682 IN denotes between
T16267 665-674 VBG denotes signaling
T16266 662-664 IN denotes in
T16265 651-661 NN denotes difference
T16264 649-650 DT denotes a
T16263 645-648 IN denotes for
T16262 633-644 NN denotes explanation
T16261 630-632 DT denotes an
T16260 624-629 VB denotes offer
T16259 620-623 MD denotes may
T16258 614-619 WDT denotes which
T16257 612-613 , denotes ,
T16256 611-612 NNP denotes ]
T16255 609-611 CD denotes 50
T16254 608-609 NNP denotes [
T16253 603-607 NNP denotes PI3K
T16252 599-602 IN denotes via
T16251 593-598 NN denotes place
T16250 588-592 VB denotes take
T16249 583-587 RB denotes also
T16248 579-582 MD denotes can
T16247 574-578 NNP denotes NFκB
T16246 571-573 IN denotes of
T16245 560-570 NNP denotes Activation
T16244 558-559 . denotes .
T16243 557-558 NNP denotes ]
T16242 555-557 CD denotes 49
T16241 554-555 NNP denotes [
T16240 548-553 NNS denotes cells
T16239 546-547 NNP denotes T
T16238 543-545 IN denotes in
T16237 538-542 NNP denotes NFAT
T16236 535-537 IN denotes of
T16235 524-534 NN denotes activation
T16234 520-523 DT denotes the
T16233 517-519 IN denotes in
T16232 508-516 VBN denotes involved
T16231 505-507 VB denotes be
T16230 502-504 TO denotes to
T16229 493-501 VBN denotes reported
T16228 488-492 VBN denotes been
T16227 484-487 VBZ denotes has
T16226 479-483 NNP denotes PI3K
T16225 475-478 IN denotes via
T16224 465-474 VBG denotes Signaling
T16223 463-464 . denotes .
T16222 462-463 NNP denotes ]
T16221 460-462 CD denotes 48
T16220 459-460 NNP denotes [
T16219 448-458 NN denotes production
T16218 442-447 JJ denotes IL-1β
T16217 438-441 RB denotes not
T16216 434-437 CC denotes but
T16215 426-433 NN denotes sIL-1RA
T16214 417-425 VBZ denotes controls
T16213 405-416 RB denotes selectively
T16212 397-404 NN denotes pathway
T16211 392-396 NNP denotes PI3K
T16210 388-391 DT denotes the
T16209 377-387 NNS denotes leukocytes
T16208 358-376 JJ denotes septic/LPS-adapted
T16207 355-357 IN denotes in
T16206 350-354 IN denotes that
T16205 337-349 VBN denotes demonstrated
T16204 332-336 VBN denotes been
T16203 328-331 VBZ denotes has
T16202 325-327 PRP denotes It
T16201 323-324 . denotes .
T16200 322-323 NNP denotes ]
T16199 317-322 CD denotes 22,37
T16198 316-317 NNP denotes [
T16197 306-315 NN denotes treatment
T16196 303-305 NNP denotes GP
T16195 300-302 IN denotes by
T16194 290-299 VBN denotes sustained
T16193 287-289 VB denotes be
T16192 283-286 MD denotes may
T16191 276-282 NN denotes effect
T16190 271-275 DT denotes this
T16189 267-270 CC denotes and
T16188 265-266 NNP denotes ]
T16187 263-265 CD denotes 44
T16186 262-263 NNP denotes [
T16185 252-261 VBG denotes signaling
T16184 248-251 IN denotes for
T16183 240-247 NN denotes pathway
T16182 235-239 NNP denotes PI3K
T16181 231-234 DT denotes the
T16180 227-230 VB denotes use
T16179 224-226 TO denotes to
T16178 218-223 VBN denotes shown
T16177 213-217 VBN denotes been
T16176 209-212 VBZ denotes has
T16175 202-208 CD denotes TSST-1
T16174 200-201 . denotes .
T16173 199-200 NNP denotes ]
T16172 194-199 CD denotes 43-45
T16171 193-194 NNP denotes [
T16170 186-192 NNP denotes TSST-1
T16169 182-185 CC denotes and
T16168 178-181 NNP denotes LPS
T16167 170-177 IN denotes between
T16166 161-169 NNS denotes pathways
T16165 151-160 VBG denotes signaling
T16164 148-150 IN denotes in
T16163 136-147 NNS denotes differences
T16162 127-135 JJ denotes balanced
T16161 116-126 RB denotes delicately
T16160 113-115 TO denotes to
T16159 102-112 VBN denotes attributed
T16158 99-101 VB denotes be
T16157 95-98 MD denotes may
T16156 93-94 , denotes ,
T16155 88-93 NN denotes study
T16154 83-87 DT denotes this
T16153 80-82 IN denotes in
T16152 71-79 VBD denotes observed
T16151 62-70 NN denotes response
T16150 55-61 JJ denotes immune
T16149 43-54 JJ denotes LPS-induced
T16148 39-42 DT denotes the
T16147 36-38 IN denotes on
T16146 33-35 NNP denotes GP
T16145 30-32 IN denotes of
T16144 22-29 NNS denotes effects
T16143 11-21 JJ denotes modulating
T16142 4-10 JJR denotes weaker
T16141 0-3 DT denotes The
R10993 T16141 T16144 det The,effects
R10994 T16142 T16144 amod weaker,effects
R10995 T16143 T16144 amod modulating,effects
R10996 T16144 T16152 nsubj effects,observed
R10998 T16145 T16144 prep of,effects
R10999 T16146 T16145 pobj GP,of
R11001 T16147 T16144 prep on,effects
R11002 T16148 T16151 det the,response
R11003 T16149 T16151 amod LPS-induced,response
R11004 T16150 T16151 amod immune,response
R11006 T16151 T16147 pobj response,on
R11007 T16152 T16152 ROOT observed,observed
R11009 T16153 T16152 prep in,observed
R11010 T16154 T16155 det this,study
R11011 T16155 T16153 pobj study,in
R11013 T16156 T16159 punct ",",attributed
R11014 T16157 T16159 aux may,attributed
R11015 T16158 T16159 auxpass be,attributed
R11016 T16159 T16152 ccomp attributed,observed
R11017 T16160 T16159 prep to,attributed
R11018 T16161 T16162 advmod delicately,balanced
R11020 T16162 T16163 amod balanced,differences
R11021 T16163 T16160 pobj differences,to
R11022 T16164 T16163 prep in,differences
R11023 T16165 T16164 pcomp signaling,in
R11025 T16166 T16165 dobj pathways,signaling
R11026 T16167 T16166 prep between,pathways
R11029 T16168 T16167 pobj LPS,between
R11031 T16169 T16168 cc and,LPS
R11032 T16170 T16171 compound TSST-1,[
R11034 T16171 T16168 conj [,LPS
R11035 T16172 T16173 compound 43-45,]
R11036 T16173 T16168 conj ],LPS
R11038 T16174 T16152 punct .,observed
R11039 T16175 T16178 nsubjpass TSST-1,shown
R11040 T16176 T16178 aux has,shown
R11042 T16177 T16178 auxpass been,shown
R11043 T16178 T16178 ROOT shown,shown
R11044 T16179 T16180 aux to,use
R11045 T16180 T16178 xcomp use,shown
R11047 T16181 T16183 det the,pathway
R11048 T16182 T16183 compound PI3K,pathway
R11049 T16183 T16180 dobj pathway,use
R11051 T16184 T16180 prep for,use
R11052 T16185 T16184 pcomp signaling,for
R11053 T16186 T16185 dobj [,signaling
R11055 T16187 T16188 nummod 44,]
R11056 T16188 T16185 dobj ],signaling
R11057 T16189 T16188 cc and,]
R11059 T16190 T16191 det this,effect
R11060 T16191 T16188 conj effect,]
R11061 T16192 T16194 aux may,sustained
R11063 T16193 T16194 auxpass be,sustained
R11064 T16194 T16178 conj sustained,shown
R11065 T16195 T16194 agent by,sustained
R11066 T16196 T16197 compound GP,treatment
R11067 T16197 T16200 compound treatment,]
R11068 T16198 T16200 compound [,]
R11070 T16199 T16200 compound "22,37",]
R11071 T16200 T16195 pobj ],by
R11072 T16201 T16178 punct .,shown
R11074 T16202 T16205 nsubjpass It,demonstrated
R11075 T16203 T16205 aux has,demonstrated
R11076 T16204 T16205 auxpass been,demonstrated
R11078 T16205 T16205 ROOT demonstrated,demonstrated
R11079 T16206 T16214 mark that,controls
R11080 T16207 T16214 prep in,controls
R11083 T16208 T16209 amod septic/LPS-adapted,leukocytes
R11084 T16209 T16207 pobj leukocytes,in
R11086 T16210 T16212 det the,pathway
R11087 T16211 T16212 compound PI3K,pathway
R11088 T16212 T16214 nsubj pathway,controls
R11090 T16213 T16214 advmod selectively,controls
R11091 T16214 T16205 ccomp controls,demonstrated
R11092 T16215 T16214 dobj sIL-1RA,controls
R11094 T16216 T16215 cc but,sIL-1RA
R11095 T16217 T16218 neg not,IL-1β
R11097 T16218 T16219 amod IL-1β,production
R11098 T16219 T16220 compound production,[
R11099 T16220 T16215 conj [,sIL-1RA
R11101 T16221 T16222 nummod 48,]
R11102 T16222 T16215 conj ],sIL-1RA
R11103 T16223 T16205 punct .,demonstrated
R11105 T16224 T16229 nsubjpass Signaling,reported
R11106 T16225 T16224 prep via,Signaling
R11107 T16226 T16225 pobj PI3K,via
R11109 T16227 T16229 aux has,reported
R11110 T16228 T16229 auxpass been,reported
R11111 T16229 T16229 ROOT reported,reported
R11114 T16230 T16232 aux to,involved
R11115 T16231 T16232 auxpass be,involved
R11116 T16232 T16229 xcomp involved,reported
R11118 T16233 T16232 prep in,involved
R11119 T16234 T16235 det the,activation
R11120 T16235 T16233 pobj activation,in
R11122 T16236 T16235 prep of,activation
R11123 T16237 T16236 pobj NFAT,of
R11125 T16238 T16235 prep in,activation
R11126 T16239 T16240 compound T,cells
R11127 T16240 T16238 pobj cells,in
R11129 T16241 T16243 nmod [,]
R11130 T16242 T16243 nummod 49,]
R11131 T16243 T16235 appos ],activation
R11133 T16244 T16229 punct .,reported
R11134 T16245 T16250 nsubj Activation,take
R11135 T16246 T16245 prep of,Activation
R11137 T16247 T16246 pobj NFκB,of
R11138 T16248 T16250 aux can,take
R11139 T16249 T16250 advmod also,take
R11141 T16250 T16250 ROOT take,take
R11142 T16251 T16250 dobj place,take
R11143 T16252 T16250 prep via,take
R11145 T16253 T16254 compound PI3K,[
R11146 T16254 T16256 nmod [,]
R11147 T16255 T16256 nummod 50,]
R11149 T16256 T16252 pobj ],via
R11150 T16257 T16256 punct ",",]
R11151 T16258 T16260 nsubj which,offer
R11153 T16259 T16260 aux may,offer
R11154 T16260 T16256 relcl offer,]
R11155 T16261 T16262 det an,explanation
R11157 T16262 T16260 dobj explanation,offer
R11158 T16263 T16262 prep for,explanation
R11159 T16264 T16265 det a,difference
R11161 T16265 T16263 pobj difference,for
R11162 T16266 T16265 prep in,difference
R11163 T16267 T16266 pcomp signaling,in
R11164 T16268 T16267 prep between,signaling
R11165 T16269 T16268 pobj GP,between
R11166 T16270 T16269 punct (,GP
R11168 T16271 T16269 appos PI3K,GP
R11169 T16272 T16269 punct ),GP
R11170 T16273 T16269 cc and,GP
R11172 T16274 T16269 conj LPS,GP
R11173 T16275 T16277 punct (,kinase
R11174 T16276 T16277 amod mitogen-activated,kinase
R11176 T16277 T16269 appos kinase,GP
R11177 T16278 T16277 acl signaling,kinase
R11178 T16279 T16277 punct ),kinase
R11180 T16280 T16250 punct .,take
R11181 T16281 T16282 det This,idea
R11182 T16282 T16285 nsubjpass idea,supported
R11183 T16283 T16285 aux may,supported
R11185 T16284 T16285 auxpass be,supported
R11186 T16285 T16285 ROOT supported,supported
R11188 T16286 T16285 agent by,supported
R11190 T16287 T16288 det another,study
R11191 T16288 T16286 pobj study,by
R11193 T16289 T16288 acl showing,study
R11194 T16290 T16289 dobj that,showing
R11195 T16291 T16289 prep despite,showing
R11197 T16292 T16293 det the,use
R11198 T16293 T16291 pobj use,despite
R11199 T16294 T16293 prep of,use
R11201 T16295 T16296 amod similar,PRR
R11202 T16296 T16294 pobj PRR,of
R11204 T16297 T16296 punct ",",PRR
R11205 T16298 T16296 conj LPS,PRR
R11206 T16299 T16298 cc and,LPS
R11208 T16300 T16298 conj peptidoglycan,LPS
R11209 T16301 T16293 prep activated,use
R11210 T16302 T16304 det the,gene
R11212 T16303 T16304 compound IL-1RA,gene
R11213 T16304 T16301 dobj gene,activated
R11214 T16305 T16301 prep through,activated
R11215 T16306 T16308 amod different,proteins
R11216 T16307 T16308 amod mechanisms/DNA-binding,proteins
R11217 T16308 T16305 pobj proteins,through
R11219 T16309 T16301 cc and,activated
R11220 T16310 T16301 conj acted,activated
R11221 T16311 T16310 advmod synergistically,acted
R11223 T16312 T16310 prep in,acted
R11224 T16313 T16312 pobj combination,in
R11225 T16314 T16310 punct ",",acted
R11227 T16315 T16310 advcl suggestive,acted
R11228 T16316 T16315 prep of,suggestive
R11229 T16317 T16316 pobj signals,of
R11231 T16318 T16319 nsubj which,are
R11232 T16319 T16317 relcl are,signals
R11233 T16320 T16319 neg not,are
R11235 T16321 T16319 acomp equivalent,are
R11236 T16322 T16321 prep in,equivalent
R11237 T16323 T16324 det all,parts
R11239 T16324 T16322 pobj parts,in
R11240 T16325 T16327 nmod [,]
R11241 T16326 T16327 nummod 51,]
R11244 T16327 T16315 dep ],suggestive
R11245 T16328 T16285 punct .,supported

bionlp-st-ge-2016-test-tees

Id Subject Object Predicate Lexical cue
T12514 836-849 Protein denotes peptidoglycan
T12513 828-831 Protein denotes LPS
T12512 823-826 Protein denotes PRR
T12511 560-570 Positive_regulation denotes Activation
T12510 687-691 Protein denotes PI3K
T12509 683-685 Protein denotes GP
T12508 574-578 Protein denotes NFκB
T12507 524-534 Positive_regulation denotes activation
T12506 538-542 Protein denotes NFAT
T12505 479-483 Protein denotes PI3K
T12504 417-425 Regulation denotes controls
T12503 417-425 Regulation denotes controls
T12502 448-458 Gene_expression denotes production
T12501 448-458 Gene_expression denotes production
T12500 442-447 Protein denotes IL-1β
T12499 426-433 Protein denotes sIL-1RA
T12498 392-396 Protein denotes PI3K
T12497 235-239 Protein denotes PI3K
T12496 202-208 Protein denotes TSST-1
T12516 850-859 Positive_regulation denotes activated
T12515 864-870 Protein denotes IL-1RA
T12517 850-859 Positive_regulation denotes activated
R7937 T12499 T12501 themeOf sIL-1RA,production
R7938 T12500 T12502 themeOf IL-1β,production
R7939 T12501 T12503 themeOf production,controls
R7940 T12502 T12504 themeOf production,controls
R7941 T12506 T12507 themeOf NFAT,activation
R7942 T12508 T12511 themeOf NFκB,Activation
R7943 T12513 T12516 causeOf LPS,activated
R7944 T12514 T12517 causeOf peptidoglycan,activated
R7945 T12515 T12516 themeOf IL-1RA,activated
R7946 T12515 T12517 themeOf IL-1RA,activated

testone

Id Subject Object Predicate Lexical cue
T11460 864-870 Protein denotes IL-1RA
T11459 538-542 Protein denotes NFAT
T11458 442-447 Protein denotes IL-1β
T11457 427-433 Protein denotes IL-1RA
T11456 202-208 Protein denotes TSST-1
T11455 186-192 Protein denotes TSST-1
T11556 850-859 Positive_regulation denotes activated
T11555 524-534 Positive_regulation denotes activation
T11554 508-516 Regulation denotes involved
T11553 448-458 Gene_expression denotes production
R7486 T11458 T11553 themeOf IL-1β,production
R7487 T11459 T11555 themeOf NFAT,activation
R7488 T11460 T11556 themeOf IL-1RA,activated
R7532 T11555 T11554 themeOf activation,involved

test3

Id Subject Object Predicate Lexical cue
T11850 864-870 Protein denotes IL-1RA
T11849 850-859 Positive_regulation denotes activated
T11848 538-542 Protein denotes NFAT
T11847 448-458 Gene_expression denotes production
T11846 442-447 Protein denotes IL-1β
T11845 429-433 Protein denotes -1RA
T11844 417-425 Regulation denotes controls
T11843 202-208 Protein denotes TSST-1
T11842 186-192 Protein denotes TSST-1
T11663 864-870 Protein denotes IL-1RA
T11662 538-542 Protein denotes NFAT
T11661 442-447 Protein denotes IL-1β
T11660 427-433 Protein denotes IL-1RA
T11659 202-208 Protein denotes TSST-1
T11658 186-192 Protein denotes TSST-1
R7631 T11845 T11847 themeOf -1RA,production
R7632 T11846 T11847 themeOf IL-1β,production
R7633 T11847 T11844 themeOf production,controls
R7634 T11850 T11849 themeOf IL-1RA,activated